EcoDrugPlus

Tachykinin Receptor 2

Ensembl ID : ENSHCOG00000000400
Gene Symbol: TACR2
3 Cross references
196 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSHCOG00000006623
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSHCOG00000007593
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSHCOG00000009871
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSHCOG00000005025
Gene Symbol: TYMP
4 Cross references
172 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSHCOG00000013427
Gene Symbol: TYMS
3 Cross references
224 Possible Orthologues:

Thyroid Hormone Receptor Beta-Like

Ensembl ID : ENSHCOG00000015168
Gene Symbol: LOC109507685
3 Cross references
388 Possible Orthologues:

Thyroid Hormone Receptor Beta-Like

Ensembl ID : ENSHCOG00000000231
Gene Symbol: LOC109518279
3 Cross references
388 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSHCOG00000010689
Gene Symbol: TRHR
3 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor-Like

Ensembl ID : ENSHCOG00000005470
Gene Symbol: LOC109518354
3 Cross references
193 Possible Orthologues:

Tissue Factor-Like

Ensembl ID : ENSHCOG00000011787
Gene Symbol: LOC109524148
2 Cross references
172 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSHCOG00000004018
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).